Zhang Fan, Ning Junhao, Chen Chen, Li Boxia, Wei Yuhui
The First Hospital of Lanzhou University, Lanzhou 730000, China.
The First Hospital of Lanzhou University, Lanzhou 730000, China.
Fitoterapia. 2024 Oct;178:106140. doi: 10.1016/j.fitote.2024.106140. Epub 2024 Jul 23.
Gardenia jasminoides Ellis (Zhi-zi), which belongs to the Rubiaceae family, has been used mainly with its fry fruit for thousands of years, and it is an herb with the homology of medicine and food. In traditional Chinese medicine (TCM) theory, Zhi-zi can be used for "Quench Xiaoke", meaning for therapying diabetes in modern medicine. Based on numerous pharmacological studies, Gardenia jasminoides Ellis (Zhi-zi), and its ingredients, mainly including iridoid glycosides and carotenoids (crocins), possess potent antioxidant and anti-inflammatory properties, and can promote insulin secretion and sensitization, stimulate GLP-1 pathway activity, and protect islet β cells and the macro- and microvascular systems. These properties are the primary reasons why Zhi-zi and its ingredients are effective in reducing glucose levels, treating diabetes, and preventing its complications. This review aims to summarize the current situation and the advances of the studies on the mechanisms of Zhi-zi in improving diabetes and its complications, and it is expected to provide useful and systematic references for future research and clinical application of Zhi-zi and its active ingredients in the therapy of diabetes and complications.
栀子,属茜草科,数千年来主要以其干燥果实入药,是一种药食同源的草药。在中医理论中,栀子可用于“消渴”,现代医学即指治疗糖尿病。基于大量药理研究,栀子及其成分,主要包括环烯醚萜苷和类胡萝卜素(藏红花素),具有强大的抗氧化和抗炎特性,可促进胰岛素分泌和增敏,刺激胰高血糖素样肽-1(GLP-1)通路活性,保护胰岛β细胞以及大、微血管系统。这些特性是栀子及其成分有效降低血糖水平、治疗糖尿病并预防其并发症的主要原因。本综述旨在总结栀子改善糖尿病及其并发症机制的研究现状与进展,期望为栀子及其活性成分在糖尿病及其并发症治疗中的未来研究和临床应用提供有益且系统的参考。